33,924 Shares in CME Group Inc. (NASDAQ:CME) Purchased by St. James Investment Company LLC

St. James Investment Company LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 33,924 shares of the financial services provider’s stock, valued at approximately $7,878,000. CME Group comprises about 1.4% of St. James Investment Company LLC’s investment portfolio, making the stock its 22nd largest holding.

A number of other large investors have also recently bought and sold shares of CME. Lake Street Advisors Group LLC increased its position in shares of CME Group by 108.7% in the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider’s stock worth $2,949,000 after acquiring an additional 6,453 shares in the last quarter. Meyer Handelman Co. acquired a new position in shares of CME Group during the 4th quarter valued at about $6,144,000. Spire Wealth Management raised its position in shares of CME Group by 37.4% in the fourth quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock valued at $307,000 after purchasing an additional 359 shares during the period. AEGON ASSET MANAGEMENT UK Plc raised its holdings in CME Group by 19.3% in the 4th quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock worth $75,730,000 after acquiring an additional 52,862 shares during the period. Finally, Unified Investment Management acquired a new position in shares of CME Group during the 4th quarter worth about $503,000. Institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on CME shares. Morgan Stanley boosted their price target on shares of CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a report on Wednesday, February 19th. Erste Group Bank upgraded CME Group to a “strong-buy” rating in a report on Monday, March 17th. Raymond James raised CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price objective on the stock in a report on Monday, March 10th. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a report on Thursday, February 13th. Finally, Oppenheimer increased their price target on shares of CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $238.93.

Check Out Our Latest Stock Analysis on CME

Insider Activity at CME Group

In other news, insider Hilda Harris Piell sold 3,984 shares of the stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the transaction, the insider now directly owns 27,046 shares in the company, valued at approximately $6,774,211.62. This represents a 12.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Julie Winkler sold 11,592 shares of the firm’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the transaction, the insider now directly owns 21,885 shares in the company, valued at $5,453,085.45. This trade represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 27,076 shares of company stock worth $6,871,496. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of NASDAQ:CME opened at $262.22 on Monday. The firm’s fifty day moving average is $249.65 and its 200-day moving average is $235.87. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The firm has a market cap of $94.49 billion, a PE ratio of 27.12, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $267.91.

CME Group (NASDAQ:CMEGet Free Report) last issued its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were issued a $1.25 dividend. This is an increase from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.91%. The ex-dividend date of this dividend was Friday, March 7th. CME Group’s payout ratio is 51.71%.

CME Group announced that its board has approved a stock buyback program on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s management believes its stock is undervalued.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.